The epidemiology of haemochromatosis: A population-based study

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 2, 2009, Pages 183-192

  Crooks, C J ^a   West, J ^a   Solaymani Dodaran, M ^a,b   Card, T R ^a,c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KING S MILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEMOCHROMATOSIS; HUMAN; IMPOTENCE; INCIDENCE; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; OSTEOARTHRITIS; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RISK FACTORS; STATISTICS AS TOPIC;

EID: 57649208499     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03874.x     Document Type: Article

References (38)

1. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. [see comment]. N Engl J Med 1999 341 : 718 24.
2. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G - > A (C282Y) HFE hereditary haemochromatosis mutation in the USA. [see comment]. Lancet 2002 359 : 211 8.
3. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001 154 : 193 206.
4. Schmitt B, Golub RM, Green R. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. [summary for patients in Ann Intern Med. 2005 Oct 4;143:I46; PMID: 16204158]. Ann Intern Med 2005 143 : 522 36.
5. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. [see comment]. N Engl J Med 2005 352 : 1769 78.
6. Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008 358 : 221 30.
7. Sherrington CA, Knuiman MW, Divitini ML, Bartholomew HC, Cullen DJ, Olynyk JK. Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis. J Gastroenterol Hepatol 2006 21 : 595 8.
8. Mahon NG, Coonar AS, Jeffery S, et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart 2000 84 : 541 7.
9. Ellervik C, Tybjaerg-Hansen A, Grande P, Appleyard M, Nordestgaard BG. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study. [see comment]. Circulation 2005 112 : 185 93.
10. Halsall DJ, McFarlane I, Luan J, Cox TM, Wareham NJ. Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study. Hum Mol Genet 2003 12 : 1361 5.
11. Asberg A, Hveem K, Kruger O, Bjerve KS. Persons with screening-detected haemochromatosis: as healthy as the general population? Scand J Gastroenterol 2002 37 : 719 24.
12. Milman N, Pedersen P, a Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 2001 80 : 737 44.
13. Niederau C, Niederau CM, Lange S, et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med 1998 128 : 337 45.
14. Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. The American journal of medicine 1995 98 : 464 8.
15. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. [see comment]. Gastroenterology 1996 110 : 1107 19.
16. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997 25 : 162 6.
17. Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002 36 : 673 8.
18. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003 138 : 627 33.
19. Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992 15 : 655 9.
20. Phatak PD, Sham RL, Raubertas RF, et al. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med 1998 129 : 954 61.
21. Cecchetti G, Binda A, Piperno A, Nador F, Fargion S, Fiorelli G. Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 1991 12 : 224 30.
22. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997 350 : 1097 9.
23. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends 1997 87 : 36 40.
24. Jick H, Jick SS, Derby LE. Validation of Information recorded on general practioner based computerised data resource in the United Kingdom. BMJ (Clinical research ed) 1991 302 : 766 8.
25. Hubbard R, Venn A. Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database. Thorax 2000 55 : 864 6.
26. Lewis JD, Brensinger C, Bilker WB, Strom BL. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002 11 : 211 8.
27. Shah AD, Martinez C. A Comparison of the Cause of Death Recorded in the General Practice Research Database with National Mortality Statistics in England and Wales. Pharmacoepidemiol Drug Saf 2004 13 : S2 3.
28. Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology 2007 46 : 1131 7.
29. Solaymani-Dodaran M, Card TR, Aithal GP, West J. Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology 2006 131 : 1752 7.
30. Card T, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 2003 125 : 1583 90.
31. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ (Clinical research ed) 2004 329 : 716 9.
32. Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005 14 : 443 51.
33. West J. Coeliac disease: studies of its frequency and consequence PhD Nottingham : The University of Nottingham 2005.
34. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991 101 : 368 72.
35. Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. J Hepatol 2008. p. doi :.
36. Beutler E. Iron storage disease: facts, fiction and progress. Blood Cells Mol Dis 2007 39 : 140 7.
37. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clinica chimica acta; international journal of clinical chemistry 1996 245 : 139 200.
38. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996 13 : 399 408.